Samsung Medical Center

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: http://www.samsunghospital.com

Clinical Trials

Extent of ILM Removal and Its Impact on Outcomes of MH Surgery

Not Applicable

Completed

Conditions: Macular Holes

Interventions: Procedure: large-extent peeling
Procedure: small-extent peeling

First Posted Date: 2013-12-12

Last Posted Date: 2016-01-07

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 65

Registration Number: NCT02010138

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell)

Phase 2

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Biological: MG4101

First Posted Date: 2013-12-11

Last Posted Date: 2015-12-03

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 5

Registration Number: NCT02008929

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Vasopressors for Cerebral Oxygenation

Phase 1

Conditions: Hypotension
Hypoxia

Interventions: Drug: dopamine
Drug: phenylephrine

First Posted Date: 2013-12-11

Last Posted Date: 2013-12-11

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 50

Registration Number: NCT02009007

Locations: 🇰🇷
Samsung medical center, Seoul, Korea, Republic of

Effects of Cerebrolysin on Motor Recovery in Patients With Subacute Stroke

Phase 4

Completed

Conditions: Cerebrolysin

Interventions: Drug: porcine brain peptide (Cerebrolysin)
Drug: Placebo

First Posted Date: 2013-11-27

Last Posted Date: 2016-05-11

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 71

Registration Number: NCT01996761

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation

Not Applicable

Completed

Conditions: Atrial Fibrillation

Interventions: Drug: Propafenone
Drug: Dronedarone

First Posted Date: 2013-11-25

Last Posted Date: 2013-11-25

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 98

Registration Number: NCT01991119

Locations: 🇰🇷
Cardiac and Vascular Center, Seoul, Korea, Republic of

Change in Foveal Avascular Zone After Removal of Epiretinal Membrane and Internal Limiting Membrane

Not Applicable

Conditions: Epiretinal Membrane

Interventions: Procedure: epiretinal membrane and internal limiting membrane removal

First Posted Date: 2013-11-15

Last Posted Date: 2013-11-26

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 32

Registration Number: NCT01985490

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma

Phase 2

Completed

Conditions: Primary Mediastinal Large B-cell Lymphoma
Relapsed or Refractory Hodgkin Lymphoma

Interventions: Drug: Ruxolitinib

First Posted Date: 2013-10-18

Last Posted Date: 2018-11-01

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 20

Registration Number: NCT01965119

Locations: 🇰🇷
Wonju Severance Christian Hospital, Wonju, Korea, Republic of
🇰🇷
Dong-A University, Busan, Korea, Republic of
🇰🇷
Busan University Hospital, Busan, Korea, Republic of

and more 4 locations

Bortezomib Maintenance in High Risk DLBCL

Phase 2

Conditions: Diffuse Large B Cell Lymphoma

Interventions: Drug: Bortezomib

First Posted Date: 2013-10-18

Last Posted Date: 2020-10-23

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 59

Registration Number: NCT01965977

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Ulcer in Bladder Pain Syndrome Patients

Completed

Conditions: Bladder Pain Syndrome

Interventions: Procedure: Transurethral Coagulation (TUC)
Procedure: Transurethral Resection(TUR)

First Posted Date: 2013-10-17

Last Posted Date: 2017-12-14

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 126

Registration Number: NCT01963988

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Effectiveness of the Combined WLI and Hyperthermia for GI Cancer Liver Metastasis

Not Applicable

Terminated

Conditions: Hyperthermia

Interventions: Radiation: Combined hyperthermia and radiation therapy

First Posted Date: 2013-10-16

Last Posted Date: 2020-03-19

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 11

Registration Number: NCT01963117

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy